THE ROLE OF MHC-ASSOCIATED SELF-PEPTIDES IN TRANSPLANTATION AND IMMUNOSURVEILLANCE

被引:7
作者
PERREAULT, C
BROCHU, S
FONTAINE, P
TREMBLAY, N
PION, S
机构
[1] Maisonneuve-Rosemont Hospital Research Center, Montreal, QC H1T 2M4
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1994年 / 71卷 / 02期
关键词
D O I
10.1006/clin.1994.1062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The antigen-binding site of most major histocompatibility complex (MHC) class I and II antigens is occupied by self-peptides that are derived from the proteolysis of endogenous proteins following instructions provided by the molecules of the MHC themselves. Together with MHC proteins, self-peptides define our immunological self and shape the repertoire of both T cells that recognize ''nonself,'' and NK cells that may recognize ''no self.'' Endogenous proteins of all cell compartments (nucleus, cytosol, organelles, surface membrane) can yield self peptides whose expression may be either ubiquitous or lineage-specific. Their expression allows the binary recognition mechanism of T and NK cells to check the integrity of the cell genome. A better understanding of the molecular bases of the distinction between self and nonself permits us to anticipate the possibility of modifying their expression and/or their recognition in order to: (i) make the nonself acceptable as self, thereby establishing specific transplantation tolerance, (ii) reestablish tolerance of the self lost in autoimmune diseases, and (iii) induce the rejection as nonself of neoplastic cells. These objectives are particularly pertinent to the area of bone marrow transplantation, where the ultimate goal is aimed at modulating host cell allorecognition in such a way as to both potentiate the graft-versus-leukemia reaction and prevent GVHD. (C) 1994 Academic Press, Inc.
引用
收藏
页码:130 / 135
页数:6
相关论文
共 49 条
[11]   EVALUATION OF INVITRO CYTOTOXIC LYMPHOCYTE-T ASSAYS AS A PREDICTIVE TEST FOR THE OCCURRENCE OF GRAFT VS HOST-DISEASE [J].
FONTAINE, P ;
LANGLAIS, J ;
PERREAULT, C .
IMMUNOGENETICS, 1991, 34 (04) :222-226
[12]   UNEVEN TISSUE DISTRIBUTION OF MINOR HISTOCOMPATIBILITY PROTEINS VERSUS PEPTIDES IS CAUSED BY MHC EXPRESSION [J].
GRIEM, P ;
WALLNY, HJ ;
FALK, K ;
ROTZSCHKE, O ;
ARNOLD, B ;
SCHONRICH, G ;
HAMMERLING, G ;
RAMMENSEE, HG .
CELL, 1991, 65 (04) :633-640
[13]   A FAIL-SAFE MECHANISM FOR MAINTAINING SELF-TOLERANCE [J].
GUERDER, S ;
MATZINGER, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (02) :553-564
[14]   ALTERATION OF THE NATURAL-KILLER REPERTOIRE IN H-2 TRANSGENIC MICE - SPECIFICITY OF RAPID LYMPHOMA CELL CLEARANCE DETERMINED BY THE H-2 PHENOTYPE OF THE TARGET [J].
HOGLUND, P ;
GLAS, R ;
OHLEN, C ;
LJUNGGREN, HG ;
KARRE, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (02) :327-334
[15]  
HOROWITZ MM, 1990, BLOOD, V75, P555
[16]   Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry (Reprinted from Science, vol 255, March 6, 1992) [J].
Hunt, Donald F. ;
Henderson, Robert A. ;
Shabanowitz, Jeffrey ;
Sakaguchi, Kazuyasu ;
Michel, Hanspeter ;
Sevilir, Noelle ;
Cox, Andrea L. ;
Appella, Ettore ;
Engelhard, Victor H. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (05) :2669-2671
[17]   PEPTIDES PRESENTED TO THE IMMUNE-SYSTEM BY THE MURINE CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE-I-A(D) [J].
HUNT, DF ;
MICHEL, H ;
DICKINSON, TA ;
SHABANOWITZ, J ;
COX, AL ;
SAKAGUCHI, K ;
APPELLA, E ;
GREY, HM ;
SETTE, A .
SCIENCE, 1992, 256 (5065) :1817-1820
[18]   IDENTIFICATION OF SELF PEPTIDES BOUND TO PURIFIED HLA-B27 [J].
JARDETZKY, TS ;
LANE, WS ;
ROBINSON, RA ;
MADDEN, DR ;
WILEY, DC .
NATURE, 1991, 353 (6342) :326-329
[19]   SELECTIVE REJECTION OF H-2-DEFICIENT LYMPHOMA VARIANTS SUGGESTS ALTERNATIVE IMMUNE DEFENSE STRATEGY [J].
KARRE, K ;
LJUNGGREN, HG ;
PIONTEK, G ;
KIESSLING, R .
NATURE, 1986, 319 (6055) :675-678
[20]  
KUZUSHIMA K, 1990, J IMMUNOL, V144, P4536